Skip to main content
Erschienen in: Familial Cancer 2/2019

23.12.2018 | Original Article

Monoallelic MUTYH carrier status is not associated with increased breast cancer risk in a multigene panel cohort

verfasst von: Kelly Fulk, Holly LaDuca, Mary Helen Black, Dajun Qian, Yuan Tian, Amal Yussuf, Carin Espenschied, Kory Jasperson

Erschienen in: Familial Cancer | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Whether monoallelic MUTYH mutations increase female breast cancer risk remains controversial. This study aimed to determine if monoallelic MUTYH mutations are associated with increased breast cancer risk in women undergoing multigene panel testing (MGPT). The prevalence of monoallelic MUTYH mutations was compared between Non-Hispanic white female breast cancer cases (n = 30,456) and cancer-free controls (n = 12,289), all of whom underwent MGPT that included MUTYH. We tested breast cancer associations with MUTYH alleles using Fisher’s exact test, followed by multivariate logistic regression adjusted for age at testing and MGPT type ordered. Frequencies of the two most common MUTYH founder mutations, p.G396D and p.Y179C, were compared independently between the breast cancer cases and MGPT controls, as well as the healthy UK10K control population (n = 2640). Comparing cases to MGPT controls, no association was observed between female breast cancer and any monoallelic MUTYH carrier status (OR 0.86–1.36, p = 0.21–0.96). Similarly, comparisons to UK10K controls revealed no significant increase in breast cancer risk associated with p.G396D (OR 1.20, p = 0.44) or p.Y179C (OR 1.71, p = 0.24). This study did not find a significant increase in breast cancer risk associated with monoallelic MUTYH mutations.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Cleary SP, Cotterchio M, Jenkins MA et al (2009) Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology 136:1251–1260CrossRefPubMed Cleary SP, Cotterchio M, Jenkins MA et al (2009) Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology 136:1251–1260CrossRefPubMed
2.
Zurück zum Zitat Lubbe SJ, Di Bernardo MC, Chandler IP et al (2009) Clinical implications of the colorectal cancer risk associated with MUTYH mutation. J Clin Oncol 27:3975–3980CrossRefPubMed Lubbe SJ, Di Bernardo MC, Chandler IP et al (2009) Clinical implications of the colorectal cancer risk associated with MUTYH mutation. J Clin Oncol 27:3975–3980CrossRefPubMed
3.
Zurück zum Zitat Theodoratou E, Campbell H, Tenesa A et al (2010) A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants. Br J Cancer 103:1875–1884CrossRefPubMedPubMedCentral Theodoratou E, Campbell H, Tenesa A et al (2010) A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants. Br J Cancer 103:1875–1884CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Win AK, Dowty JG, Cleary SP et al (2014) Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer. Gastroenterology 146:1208–1211.e1–5CrossRefPubMed Win AK, Dowty JG, Cleary SP et al (2014) Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer. Gastroenterology 146:1208–1211.e1–5CrossRefPubMed
5.
Zurück zum Zitat Vogt S, Jones N, Christian D et al (2009) Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology 137:1976–85.e10CrossRefPubMed Vogt S, Jones N, Christian D et al (2009) Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology 137:1976–85.e10CrossRefPubMed
6.
Zurück zum Zitat Kanter-Smoler G, Björk J, Fritzell K et al (2006) Novel findings in Swedish patients with MYH-associated polyposis: mutation detection and clinical characterization. Clin Gastroenterol Hepatol 4:499–506CrossRefPubMed Kanter-Smoler G, Björk J, Fritzell K et al (2006) Novel findings in Swedish patients with MYH-associated polyposis: mutation detection and clinical characterization. Clin Gastroenterol Hepatol 4:499–506CrossRefPubMed
7.
Zurück zum Zitat Sieber OM, Lipton L, Crabtree M et al (2003) Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 348:791–799CrossRefPubMed Sieber OM, Lipton L, Crabtree M et al (2003) Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 348:791–799CrossRefPubMed
8.
Zurück zum Zitat Win AK, Hopper JL, Jenkins MA (2011) Association between monoallelic MUTYH mutation and colorectal cancer risk: a meta-regression analysis. Fam Cancer 10:1–9CrossRefPubMedPubMedCentral Win AK, Hopper JL, Jenkins MA (2011) Association between monoallelic MUTYH mutation and colorectal cancer risk: a meta-regression analysis. Fam Cancer 10:1–9CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Rennert G, Lejbkowicz F, Cohen I et al (2012) MutYH mutation carriers have increased breast cancer risk. Cancer 118:1989–1993CrossRefPubMed Rennert G, Lejbkowicz F, Cohen I et al (2012) MutYH mutation carriers have increased breast cancer risk. Cancer 118:1989–1993CrossRefPubMed
10.
Zurück zum Zitat Zhu M, Chen X, Zhang H et al (2011) AluYb8 insertion in the MUTYH gene and risk of early-onset breast and gastric cancers in the Chinese population. Asian Pac J Cancer Prev 12:1451–1455PubMed Zhu M, Chen X, Zhang H et al (2011) AluYb8 insertion in the MUTYH gene and risk of early-onset breast and gastric cancers in the Chinese population. Asian Pac J Cancer Prev 12:1451–1455PubMed
11.
Zurück zum Zitat Beiner M, Zhang W, Zhang S et al (2009) Mutations of the MYH gene do not substantially contribute to the risk of breast cancer. Breast Cancer Res Treat 114:575–578CrossRefPubMed Beiner M, Zhang W, Zhang S et al (2009) Mutations of the MYH gene do not substantially contribute to the risk of breast cancer. Breast Cancer Res Treat 114:575–578CrossRefPubMed
12.
Zurück zum Zitat Out AA, Wasielewski M, Huijts PE et al (2012) MUTYH gene variants and breast cancer in a Dutch case-control study. Breast Cancer Res Treat 134:219–227CrossRefPubMedPubMedCentral Out AA, Wasielewski M, Huijts PE et al (2012) MUTYH gene variants and breast cancer in a Dutch case-control study. Breast Cancer Res Treat 134:219–227CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Win AK, Reece JC, Dowty JG et al (2016) Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH. Int J Cancer 139:1557–1563CrossRefPubMedPubMedCentral Win AK, Reece JC, Dowty JG et al (2016) Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH. Int J Cancer 139:1557–1563CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat UK10K Consortium, Walter K, Min JL et al (2015) The UK10K project identifies rare variants in health and disease. Nature 526:82–90CrossRef UK10K Consortium, Walter K, Min JL et al (2015) The UK10K project identifies rare variants in health and disease. Nature 526:82–90CrossRef
15.
Zurück zum Zitat LaDuca H, Stuenkel AJ, Dolinsky JS et al (2014) Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients. Genet Med 16(11):830–837CrossRefPubMedPubMedCentral LaDuca H, Stuenkel AJ, Dolinsky JS et al (2014) Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients. Genet Med 16(11):830–837CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424CrossRefPubMedPubMedCentral Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Win AK, Cleary SP, Dowty JG et al (2011) Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer. Int J Cancer 129:2256–2262CrossRefPubMedPubMedCentral Win AK, Cleary SP, Dowty JG et al (2011) Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer. Int J Cancer 129:2256–2262CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Horton C, LaDuca H, McFarland R et al (2017) In laboratory clinical data we trust? Accuracy and completeness of test requisition form data in a cohort of ovarian and uterine cancer patients referred for clinical genetic testing. In: 48th annual conference of the society of gynecologic oncology; March 12–15; National Harbor, MD Horton C, LaDuca H, McFarland R et al (2017) In laboratory clinical data we trust? Accuracy and completeness of test requisition form data in a cohort of ovarian and uterine cancer patients referred for clinical genetic testing. In: 48th annual conference of the society of gynecologic oncology; March 12–15; National Harbor, MD
Metadaten
Titel
Monoallelic MUTYH carrier status is not associated with increased breast cancer risk in a multigene panel cohort
verfasst von
Kelly Fulk
Holly LaDuca
Mary Helen Black
Dajun Qian
Yuan Tian
Amal Yussuf
Carin Espenschied
Kory Jasperson
Publikationsdatum
23.12.2018
Verlag
Springer Netherlands
Erschienen in
Familial Cancer / Ausgabe 2/2019
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-018-00114-4

Weitere Artikel der Ausgabe 2/2019

Familial Cancer 2/2019 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.